A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR
Clinical trial NCT01756716 · COMPLETED
Trial details
- NCT number
- NCT01756716
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2014-09-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.